Method for measurement of vascular endothelial response to stimuli
View Patent ↗A method for evaluating the response of the vascular endothelium of a human subject to a stimulus, by observing the reaction of the endothelium before and after the topical application of a vasoactive substance, before and after application of the stimulus. The observation is carried out by at least one camera device, which may be a high-resolution spectrophotometric, THz, infrared, ultraviolet optical coherence tomography, or optical elasticity camera, which device is used to observe a skin area or areas of the subject. One device may take the measurements of the area of skin before and after topical application of a vasocative substance, or two devices may be used contemporaneously to each measure an area of skin with and without the topical substance. The device may be applied to the skin, or remote from the skin, or implanted in or under the skin.
1 . A method for evaluating a response of a vascular endothelium of a human subject to a stimulus, the method comprising the steps, of:
a) determining at least one baseline value of a first observed area of a subject's skin by digitally imaging a vasculature in the first observed area with a first imaging device prior to any application of a vasoactive substance in the first observed area, wherein the first imaging device is an optical coherence tomography (OCT) camera configured to obtain high-resolution cross-sectional images of the skin tissue and visualize the diameter of epidermal and subdermal blood vessels within the observed area, the first imaging device outputting at least one first digital image of at least one of an epidermal vessel or a subdermal vessel, the at least one baseline value corresponding to the at least one first digital image, wherein the at least one baseline value comprises a baseline capillary diameter;
b) applying the vasoactive substance topically to the first observed area;
c) determining at least one vasoactivated value of the first observed area by digitally imaging the vasculature in the first observed area with the first imaging device, wherein the first imaging device is further configured to measure changes in the diameter of the epidermal and subdermal vessels in response to the vasoactive substance, the first imaging device outputting at least one second digital image of at least one of the epidermal vessel or the subdermal vessel, the at least one vasoactivated value corresponding to the at least one second digital image, wherein the at least one vasoactived value comprises a vasoactivated capillary diameter;
d) comparing the at least one vasoactivated value with the at least one baseline value to determine the response of the vascular endothelium of the human subject prior to the stimulus;
e) applying the stimulus to the human subject;
f) repeating steps (a)-(c);
g) comparing the at least one vasoactivated value from step (f) with the at least one baseline value from step (f) to determine the response of the vascular endothelium of the human subject to the stimulus.
2 . The method of claim 1 wherein the at least one baseline value of step (a) is a time series of baseline values and the at least one vasoactivated value of step (c) is a time series of vasoactivated values.
3 . The method of claim 1 wherein the stimulus is physical exercise by the human subject.
4 . The method of claim 1 wherein the stimulus is a medication administered to the human subject.
5 . The method of claim 1 wherein the stimulus is a therapy administered to the human subject.
6 . The method of claim 1 wherein the first imaging device is disposed on the skin of the human subject.
7 . The method of claim 1 wherein the first imaging device is implanted within or beneath the skin of the human subject.
8 . The method of claim 1 wherein the at least one first digital image of step (a) and the at least one second digital image of step (c) are transmitted from the first imaging device, respectively, to a computer, smart device, or cloud server.
9 . A method for evaluating a response of a vascular endothelium of a human subject to a stimulus, the method comprising the steps, of:
a) determining at least one baseline value of a first observed area of a subject's skin by digitally imaging a vasculature in the first observed area with a first imaging device without any application of a vasoactive substance in the first observed area, wherein the first imaging device is an optical coherence tomography (OCT) camera configured to obtain high-resolution cross-sectional images of the skin tissue and visualize the diameter of epidermal and subdermal blood vessels within the observed area, the first imaging device outputting at least one first digital image of at least one of an epidermal vessel or a subdermal vessel, the at least one baseline value corresponding to the at least one first digital image, wherein the at least one baseline value comprises a baseline capillary diameter;
b) contemporaneously with step (a), determining at least one vasoactivated value of a second observed area to which a vasoactive substance has been topically applied, by digitally imaging vasculature in the second observed area with a second imaging device, the second imaging device being a terahertz camera, infrared camera, ultraviolet camera, optical coherence tomography (OCT) camera, or optical coherence elasticity (OCE) camera, and not a colorimeter, wherein the second imaging device is further configured to measure changes in the diameter of the epidermal and subdermal vessels in response to the vasoactive substance, the second imaging device outputting at least one second digital image of at least one of an epidermal vessel or a subdermal vessel, the at least one vasoactivated value corresponding to the at least one second digital image, wherein the at least one vasoactived value comprises a vasoactivated capillary diameter;
c) comparing the at least one vasoactivated value with the at least one baseline value to determine the response of the vascular endothelium of the human subject prior to the stimulus, d) applying the stimulus to the human subject;
e) repeating steps (a) and (b);
f) comparing the at least one vasoactivated value from step (e) with the at least one baseline value from step (e) to determine the response of the vascular endothelium of the human subject to the stimulus.
10 . The method of claim 9 wherein the at least one baseline value of step (a) is a time series of baseline values and the at least one vasoactivated value of step (c) is a time series of vasoactivated values.
11 . The method of claim 9 wherein the stimulus is physical exercise by the human subject.
12 . The method of claim 9 wherein the stimulus is a medication administered to the human subject.
13 . The method of claim 9 wherein the stimulus is a therapy administered to the human subject.
14 . The method of claim 9 wherein the first imaging device or the second imaging device is implanted within or beneath the skin of the human subject.
15 . The method of claim 9 wherein the at least one first digital image of step (a) and the at least one second digital image of step (b) are transmitted from the first imaging device and the second imaging device, respectively, to a computer, smart device, or cloud server.